- Home
- BMRA vs PSTV Comparison
BMRA vs PSTV Comparison
Compare BMRA & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- PSTV
- Stock Information
- Founded
- BMRA 1971
- PSTV 1996
- Country
- BMRA United States
- PSTV United States
- Employees
- BMRA N/A
- PSTV N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PSTV Medical/Dental Instruments
- Sector
- BMRA Health Care
- PSTV Health Care
- Exchange
- BMRA Nasdaq
- PSTV Nasdaq
- Market Cap
- BMRA 7.4M
- PSTV 9.4M
- IPO Year
- BMRA N/A
- PSTV N/A
- Fundamental
- Price
- BMRA $0.33
- PSTV $1.40
- Analyst Decision
- BMRA
- PSTV Strong Buy
- Analyst Count
- BMRA 0
- PSTV 2
- Target Price
- BMRA N/A
- PSTV $14.00
- AVG Volume (30 Days)
- BMRA 68.2K
- PSTV 86.1K
- Earning Date
- BMRA 10-15-2024
- PSTV 10-29-2024
- Dividend Yield
- BMRA N/A
- PSTV N/A
- EPS Growth
- BMRA N/A
- PSTV N/A
- EPS
- BMRA N/A
- PSTV N/A
- Revenue
- BMRA $5,509,000.00
- PSTV $5,509,000.00
- Revenue This Year
- BMRA N/A
- PSTV $11.13
- Revenue Next Year
- BMRA N/A
- PSTV N/A
- P/E Ratio
- BMRA N/A
- PSTV N/A
- Revenue Growth
- BMRA 1.74
- PSTV 113.20
- 52 Week Low
- BMRA $0.24
- PSTV $0.97
- 52 Week High
- BMRA $2.13
- PSTV $2.78
- Technical
- Relative Strength Index (RSI)
- BMRA 47.85
- PSTV 48.32
- Support Level
- BMRA $0.28
- PSTV $1.20
- Resistance Level
- BMRA $0.35
- PSTV $1.45
- Average True Range (ATR)
- BMRA 0.04
- PSTV 0.11
- MACD
- BMRA 0.00
- PSTV 0.01
- Stochastic Oscillator
- BMRA 41.67
- PSTV 66.67
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).